FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...